CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
1.030
-0.040 (-3.74%)
At close: May 30, 2025, 4:00 PM
1.069
+0.039 (3.82%)
After-hours: May 30, 2025, 7:36 PM EDT
CNS Pharmaceuticals Employees
As of December 31, 2024, CNS Pharmaceuticals had 5 total employees, including 3 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,122,875
Market Cap
5.63M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CNSP News
- 15 days ago - CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update - Accesswire
- 18 days ago - CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Accesswire
- 18 days ago - CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287 - Accesswire
- 2 months ago - CNS Pharmaceuticals Reports Full Year 2024 Financial Results - Accesswire
- 2 months ago - CNS Pharma's Cancer Drug Misses Survival Goal But May Offer Fewer Side Effects - Benzinga
- 2 months ago - CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme - Accesswire
- 3 months ago - CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing - Accesswire
- 3 months ago - CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum - Accesswire